Coloplast A/S
CSE:COLO B
Coloplast A/S
CSE:COLO B
Price:
429.7
DKK
0.68%
Market Cap:
kr96.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Coloplast A/S
CSE:COLO B
|
DK |
Relative Value
The Relative Value of one
COLO B
stock under the Base Case scenario is
685.78
DKK.
Compared to the current market price of 429.7 DKK,
Coloplast A/S
is
Undervalued by 37%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
COLO B
Relative Value
Base Case
685.78
DKK
Undervaluation 37%
Multiples Across Competitors
COLO B Competitors Multiples
Coloplast A/S Competitors
Coloplast A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.2B DKK | 3.5 | 24.4 | 12.9 | 15.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10.1 | 36.8 | 26.6 | 31.9 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56.1B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 3.5 | 37.2 | 14.3 | 27.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD | 3.1 | 30.1 | 12.9 | 17.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.3 | 32.7 | 11.5 | 17.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.4 | 16.8 | 54.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.2B CNY | 8.3 | 22.9 | 20.6 | 20.6 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36.8B CNY | 3.7 | 21.6 | 31.9 | 31.9 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
848.5B JPY | 6.5 | 48 | 22.6 | 30.8 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.9B CHF | 4.8 | 19.6 | 12.7 | 17.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
